Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Authors
Keywords
-
Journal
NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 24, Issue 7, Pages 578-587
Publisher
Springer Nature
Online
2017-05-29
DOI
10.1038/nsmb.3414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity
- (2016) Marios G Koliopoulos et al. EMBO JOURNAL
- Structural insights into the catalysis and regulation of E3 ubiquitin ligases
- (2016) Lori Buetow et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway
- (2016) Jacint G. Sanchez et al. Cell Reports
- Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
- (2015) M. Andreeff et al. CLINICAL CANCER RESEARCH
- Activation of a Primed RING E3-E2–Ubiquitin Complex by Non-Covalent Ubiquitin
- (2015) Lori Buetow et al. MOLECULAR CELL
- Structural basis for the RING-catalyzed synthesis of K63-linked ubiquitin chains
- (2015) Emma Branigan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural basis for the RING-catalyzed synthesis of K63-linked ubiquitin chains
- (2015) Emma Branigan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- AKT mediates actinomycin D-induced p53 expression
- (2015) Chih-Shou Chen et al. Oncotarget
- Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage
- (2014) Laura A. Tollini et al. CANCER CELL
- Structure of a RING E3 Trapped in Action Reveals Ligation Mechanism for the Ubiquitin-like Protein NEDD8
- (2014) Daniel C. Scott et al. CELL
- Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction
- (2014) Q. Cheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
- (2013) Qingjie Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3
- (2013) Hao Dou et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MDMX contains an autoinhibitory sequence element
- (2013) M. Bista et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small molecules that bind the Mdm2 RING stabilize and activate p53
- (2012) P. Roxburgh et al. CARCINOGENESIS
- Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers
- (2012) Pavlina Dolezelova et al. CELL CYCLE
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- Structure of an E3:E2∼Ub Complex Reveals an Allosteric Mechanism Shared among RING/U-box Ligases
- (2012) Jonathan N. Pruneda et al. MOLECULAR CELL
- Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis
- (2012) Anna Plechanovová et al. NATURE
- BIRC7–E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer
- (2012) Hao Dou et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage
- (2011) Q. Cheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanism of ubiquitylation by dimeric RING ligase RNF4
- (2011) Anna Plechanovová et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
- (2011) V. Pant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
- (2011) L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Specific activation of the p53 pathway by low dose actinomycin D: A new route to p53 based cyclotherapy
- (2010) Meng Ling Choong et al. CELL CYCLE
- Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase
- (2010) Saravanakumar Iyappan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
- (2008) K Linke et al. CELL DEATH AND DIFFERENTIATION
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More